Quarterly report · Q1
3353.TEDINET S100U1RT
Period2024-03-01 → 2024-05-31
Filed2024-07-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.2bn | 2024-03-01 → 2024-05-31 | Cons. | Net sales |
| Revenue | ¥39.9bn | 2023-03-01 → 2024-02-29 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.7bn | 2023-03-01 → 2023-05-31 | Cons. | Net sales |
| Operating income | ¥429m | 2024-03-01 → 2024-05-31 | Cons. | Operating income |
| Operating income | ¥294m | 2023-03-01 → 2023-05-31 | Cons. | Operating income |
| Ordinary income | ¥431m | 2024-03-01 → 2024-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2023-03-01 → 2024-02-29 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥338m | 2023-03-01 → 2023-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥671m | 2024-03-01 → 2024-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥375m | 2023-03-01 → 2023-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥429m | 2024-03-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.0bn | 2023-03-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥212m | 2023-03-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥436m | 2024-03-01 → 2024-05-31 | Cons. | Profit loss |
| Net income | ¥224m | 2023-03-01 → 2023-05-31 | Cons. | Profit loss |
| Total assets | ¥31.8bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥31.7bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥28.1bn | at 2023-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥17.6bn | at 2024-05-31 | Cons. | Liabilities |
| Total liabilities | ¥17.8bn | at 2024-02-29 | Cons. | Liabilities |
| Net assets / equity | ¥14.2bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥13.8bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2023-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.9bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.7bn | at 2024-02-29 | Cons. | Cash and deposits |
| EPS (basic) | ¥114.23 | 2024-03-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥276.7 | 2023-03-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.42 | 2023-03-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 42.7% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.8% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.2% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-03-01 → 2024-05-31 | −¥204m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-03-01 → 2024-05-31 | −¥204m |
| Reconciling Itemsreconciling | segment profit | 2024-03-01 → 2024-05-31 | −¥58m |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥5.8bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥5.8bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | segment profit | 2024-03-01 → 2024-05-31 | ¥311m |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥1.9bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥1.9bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥150,000 |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | segment profit | 2024-03-01 → 2024-05-31 | ¥50m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥3.6bn |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥3.4bn |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥202m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | segment profit | 2024-03-01 → 2024-05-31 | ¥94m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥46m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥45m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥1m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | segment profit | 2024-03-01 → 2024-05-31 | ¥32m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-03-01 → 2024-05-31 | ¥11.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-03-01 → 2024-05-31 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥204m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-03-01 → 2024-05-31 | ¥487m |
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-05-31 | −¥277m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-05-31 | −¥277m |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-05-31 | −¥141m |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥329m |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥2.0bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥2.0bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥150,000 |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥50m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥1.1bn |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥810m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥275m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥23m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥47m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥46m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥1m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥34m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-03-01 → 2023-05-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-03-01 → 2023-05-31 | ¥8.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥277m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-03-01 → 2023-05-31 | ¥435m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 364
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -140991000 | JPY |
| Operating income | Prior1YTDDuration | 294402000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember | 5823473000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember | 1923437000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember | 3391614000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember | 45243000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 11183769000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 11183769000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember | 150000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember | 202467000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember | 1163000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 203781000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -203781000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember | 5823473000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember | 1923587000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember | 3594081000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember | 46407000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 11387550000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -203781000 | JPY |
| Net sales | CurrentYTDDuration | 11183769000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember | 310692000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember | 49963000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember | 94125000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember | 32382000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 487163000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -57962000 | JPY |
| Operating income | CurrentYTDDuration | 429200000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)東海財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-07-12 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第40期第１四半期（自 2024年３月１日 至 2024年５月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社メディカル一光グループ | |
| Company name in english cover page | FilingDateInstant | Medical Ikkou Group Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 南野 利久 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)三重県津市西丸之内36番25号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)059－226－1193（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)常務取締役 経理部・関東支社担当 兼 財務・ＩＲ部長 遠山 邦彦 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)三重県津市西丸之内36番25号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)059－226－1193（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)常務取締役 経理部・関東支社担当 兼 財務・ＩＲ部長 遠山 邦彦 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E03443 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 33530 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社メディカル一光グループ | |
| Filer name in english | FilingDateInstant | Medical Ikkou Group Co.,Ltd. |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |